Medicus Pharma Ltd. Common Stock
MDCX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$118.37M
Close$
$0.27
87.3% downside
Current Fair Value
87.3% downsideOvervalued by 87.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $118.37 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-1.96 |
| Beta | -0.61 |
| Outstanding Shares | 55,055,225 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | -0.16 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-6.38
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-6.68
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.76%▼ 3.09% |
|---|---|
| Total Invested | $1.18M▲ 10.82% |
| Investors Holding | 22▲ 2.00% |
About Medicus Pharma Ltd. Common Stock
16 employees
CEO: Raza Bokhari
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company ...